2025
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, Lihm J, …
Nature 639(8056), 1042–1051
251Citations
2025Year
Research Programs
Projects
Related by topic
Publication · Neoantigen, Vaccine, Immunotherapy, PDACPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerPublication · Immunotherapy, Neoantigen, PDACPembrolizumab and Olaparib in HRD Metastatic Pancreatic Cancer: The POLAR TrialPublication · PDACAlterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaPublication · PDACAssociation of ablative radiation therapy with survival among patients with inoperable pancreatic cancerPublication · ImmunotherapyAxitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trialPublication · PDACClinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Local graph
Drag to pan · scroll to zoom · drag a node to move · double-click to open